Results 171 to 180 of about 187,893 (285)

A Systematic Comparison of Alpha‐Synuclein Seed Amplification Assays for Increasing Reproducibility

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Seed amplification assays (SAAs) enable ultrasensitive detection of misfolded α‐synuclein across biofluids and tissues. Yet, heterogeneity in protocols limits cross‐study comparability and clinical translation. Here, we review α‐synuclein SAA methods and their performance across various biological matrices.
Manuela Amaral‐do‐Nascimento   +3 more
wiley   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor. [PDF]

open access: yesNat Commun, 2022
Liu J   +11 more
europepmc   +1 more source

Targeting PAR1 biased signaling with parmodulin reduces thromboinflammation and acute lung injury in sickle cell disease. [PDF]

open access: yesBlood Adv
Ramadas N   +7 more
europepmc   +1 more source

EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia. [PDF]

open access: yesJCI Insight, 2022
Bochenek ML   +14 more
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

Neutrophil cathepsin G potentiates biased signaling through protease-activated receptor 4. [PDF]

open access: yesBlood Adv
Kendrick NC   +5 more
europepmc   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle   +4 more
wiley   +1 more source

Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor. [PDF]

open access: yesNat Commun
Suno-Ikeda C   +22 more
europepmc   +1 more source

Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling. [PDF]

open access: yesTrends Biochem Sci, 2022
Seyedabadi M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy